Cordyceps Sunshine Biotech Holdings Co., Ltd. Investing Cash Flow
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) reported Investing Cash Flow of -$305.64 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-05-15
- Cordyceps Sunshine Biotech Holdings Co., Ltd. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was $1.22M.
- Cordyceps Sunshine Biotech Holdings Co., Ltd. net cash provided by (used in) investing activities for the quarter ending 2022-12-31 was -$1.46K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 8 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | -$305.64K 20-F · filed 2026-05-15 | ||||
| 2023-12-31 | $1.22M derived: 20-F 12 month − 6-K 9 month · filed 2026-05-15 | -$319.82K 20-F · filed 2026-05-15 | -$121.56K 20-F · filed 2024-07-05 | ||
| 2023-09-30 | -$1.54M 6-K · filed 2023-11-13 | ||||
| 2022-12-31 | -$1.46K derived: 20-F/A 12 month − 6-K 9 month · filed 2025-09-23 | -$475.00 20-F/A · filed 2025-09-23 | |||
| 2022-09-30 | $981.00 6-K · filed 2023-11-13 | ||||
| 2021-12-31 | -$110.81K 20-F/A · filed 2025-09-23 | ||||
| 2020-12-31 | -$1.50M 20-F · filed 2023-05-15 |